Trial intelligence / Profile preview

Venetoclax + azacitidine for de novo higher-risk chronic myelomonocytic leukemia

ChiCTR2200061423Phase 4Not yet recruiting

Sponsor

First Affiliated Hospital, Zhejiang University School of Medicine

Start

Jun 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

1